StockWatch
·

NATCO PHARMA LTD. Q1 FY26 Results

NATCOPHARMQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue1.3K8.8%
Total Income1.4K8.0%
Expenditure818.704.8%
PBT571.9013.1%
Net Profit480.3018.3%
OPM42.97%1.92pp
NPM34.54%3.00pp
EPS26.8418.2%
View full financials

Informational and educational content only. Not investment advice.